Dawn simulation

1. Introduction

Version followed: dawn simulation as described in the controlled trials of the Avery group (University of Washington; sigmoidal dawn) and of Michael and Jiuan Su Terman (New York State Psychiatric Institute / Columbia; naturalistic dawn), with evidence status from the Golden et al. 2005 meta-analysis and current patient-facing and payer sources. This guide is written for the psychotherapist working alongside a prescriber, GP or sleep specialist; it gives no light intensities, ramp durations, start times or schedules. Those settings are specified in trial reports and guidelines and must be set with the prescriber or sleep specialist. For bright-light therapy itself (light boxes used after waking), see 032 Bright-light therapy; this entry does not repeat it.

Dawn simulation uses a bedside light controlled by a timer that brightens gradually during the last part of the night, so that the sleeper is exposed to a slowly rising, relatively dim signal through closed eyelids and usually wakes as it reaches its peak. It is often sold as a "wake-up light" or "sunrise alarm clock". The rationale given by its researchers is chronobiological: animal and human work suggests the circadian clock is sensitive to the dim, rising light at the end of the night, and early-morning light advances the clock more than light at other times; the idea of change is that re-timing or strengthening the morning signal relieves winter (seasonal) depression and eases waking [source: Wikipedia, Dawn simulation; Terman & Terman 2006 abstract page]. Its practical appeal is that treatment happens during sleep, so it asks no separate daily session of the client [source: Terman & Terman 2006; Phelps 2016].

It is a light-delivery method, not a psychotherapy. Psychotherapists do not prescribe it, but they are often the first to hear that a client has bought or is considering a wake-up light, and they are well placed to screen, inform, coordinate and monitor [synthesis].

2. Framework

Dawn simulation has no published phase model of its own. The structure below combines what the trials describe with a care pathway for the psychotherapist [synthesis unless tagged].

How it has been delivered in research (descriptive only). Two signal types have been studied: a sigmoidal (S-shaped) ramp used by the Avery group, and a naturalistic dawn that imitates a spring sunrise, beginning in twilight and rising gradually over a longer period, used by the Terman group [source: Terman & Terman 2006 abstract page; Wikipedia]. Trials were home-based, ran for a few weeks during winter, used blinded symptom ratings, and compared dawn simulation with post-waking bright light and with placebo conditions (a dim "dawn pulse" or low-density negative-ion generators) [source: Terman & Terman 2006]. Exact parameters are in the original papers and are deliberately not reproduced here.

Care pathway for the psychotherapist [synthesis]:

Recognition and screening (one session or part of one): identify a seasonal pattern, sleep and waking problems, interest in or current use of a wake-up light; screen for bipolar history, eye conditions and photosensitising medicines. Move on when screening is complete and documented.
Referral and shared decision (one to two sessions, alongside the medical review): psychoeducation on what is and is not known; client takes questions to the prescriber, GP or sleep specialist, who decides whether it is suitable and how it is set. Move on once the medical professional has given an opinion (or the client has made an informed choice to use a consumer device with the GP aware of it).
Concurrent phase (throughout the winter, usually inside ordinary therapy sessions): brief check-ins on mood, sleep, energy, side effects and practicalities; continue the psychotherapy (for example CBT for seasonal depression or behavioural activation). Move on when the season ends or the prescriber changes the plan.
End of season and relapse planning (one session): review what helped, write an early-warning and autumn plan, agree when to contact the prescriber next year.

Session count: no psychotherapy session count exists for dawn simulation; contacts are embedded in the existing therapy [synthesis].

3. Guiding principles

Not the therapist's prescription. Settings, timing, suitability and combination with other treatments belong to the prescriber or sleep specialist; your role is information, screening, coordination and monitoring [source: NHS SAD treatment page, "Speak to a GP before trying light therapy"; Mayo Clinic].
State the evidence honestly. Dawn simulation has positive controlled trials but a small, largely single-group evidence base; say "promising, less established than bright light" rather than "proven" [source: Golden et al. 2005; Kaiser Permanente criteria].
Screen bipolarity before any light treatment. Light therapy can trigger hypomania or mania in vulnerable people; sources disagree about how far this applies to dim dawn signals, so treat it as a live risk [source: Golden et al. 2005; Mayo Clinic; Terman & Terman 2006; contrast Phelps 2016] [uncertain].
Ask about the eyes and medicines. Eye disease and light-sensitising medicines are reasons for medical or eye-specialist advice first [source: NHS; Mayo Clinic; AFP 2020; Kaiser].
Consumer device is not a treatment plan. A wake-up light bought online carries marketing claims, not a clinical assessment; help the client separate the two [synthesis; source: Phelps 2016 on untested apps].
Do not let a gadget replace therapy or medical care. Light-based methods sit alongside psychotherapy and medication, not instead of an assessment of depression severity and risk [source: Mayo Clinic on combining with talk therapy; synthesis].
Never advise a change. You do not tell a client to start, stop, increase or move the timing of a device, or change medicines; route those questions to the prescriber [synthesis].
Mind the household. A dawn signal can wake a bed partner on a different schedule; practicalities shape adherence [source: Terman & Terman 2006; Phelps 2016].
Monitor and pass on. Record and relay emerging hypomania, worsening depression, suicidal thoughts, sleep disruption or eye symptoms to the prescriber [synthesis].

4. Intervention inventory

Part A describes the treatment as researchers, guidelines, regulators and payers publish it, at a descriptive level. Part B gives the psychotherapist's own interventions.

A1. Dawn simulation as delivered in controlled trials

Purpose: treatment of winter (seasonal) depression; studied mainly in adults with seasonal major depression, with small numbers of people with bipolar II disorder included in at least one trial [source: Terman & Terman 2006].
How it is delivered (descriptive): a timer-controlled lamp at the bedside rises from darkness to a modest peak during the final part of sleep, ending around the planned wake time. Avery's group used a sigmoidal ramp; the Termans used a longer naturalistic twilight-to-sunrise curve. Treatment was taken at home every morning over several weeks of winter, with symptoms rated by blinded raters on a structured seasonal depression interview [source: Terman & Terman 2006 abstract page; Wikipedia]. The light level used is much weaker than a light box [source: AFP 2020; Wikipedia]. Specific intensities, ramp lengths and start times are set by the prescriber or sleep specialist from the trial literature; they are not given here.
Who delivers it: in research, psychiatric research teams. In practice the devices are bought over the counter and used at home; NHS and Mayo Clinic advise speaking to a GP or health care provider before using light therapy [source: NHS; Mayo Clinic].
Regulatory status: Mayo Clinic and Kaiser Permanente state that light boxes are not regulated by the FDA for SAD treatment [source: Mayo Clinic; Kaiser]. NHS advises buying light boxes that carry a UKCA or CE mark and emit no UV [source: NHS]. No source stated whether any dawn simulator is cleared or certified as a medical device for depression in the US, UK or EU [uncertain]; treat wake-up lights as consumer products unless the manufacturer documents otherwise.
Evidence status (as of October 2026):
- Golden et al. 2005 (meta-analysis for the American Psychiatric Association work group): dawn simulation for seasonal depression showed a significant effect across five studies, but all came from one research group, and the authors asked for independent replication [source: Golden et al. 2005].
- Avery et al. 2001 (Biological Psychiatry): reported, per a payer review, that dawn simulation was superior to bright light and placebo on remission in the largest study [source: Kaiser criteria] [uncertain].
- Terman & Terman 2006 (American Journal of Psychiatry): naturalistic dawn was an active treatment but was not superior to bright light or to the dim dawn pulse; the authors suggest dawn simulation could be considered an alternative to bright light or medication [source: Terman & Terman 2006 abstract page].
- Danilenko and colleagues (Journal of Affective Disorders, 2015, a manufacturer-supplied-device trial in Russia): in mild-to-moderate winter depression, dawn simulation and a light box gave similar reductions in symptoms; preferences split roughly evenly [source: Lumie blog; Phelps 2016] [uncertain].
- American Family Physician (2020) rates light therapy, dawn simulation and CBT as effective for SAD at its highest evidence grade, citing the 2005 meta-analysis [source: AFP 2020]. Kaiser Permanente of Washington's criteria judge the evidence insufficient for coverage [source: Kaiser]. NHS says light therapy is not usually available on the NHS because evidence of effectiveness is insufficient [source: NHS].
- The CANMAT 2023 update is reported to affirm light-therapy recommendations for seasonal and nonseasonal depression [source: UBC SAD information page]; whether it addresses dawn simulation specifically could not be checked [uncertain]. Status for nonseasonal depression, bipolar depression, delayed sleep phase or sleep inertia: no controlled evidence is described in the sources; Phelps notes there are no randomised trials in bipolar depression [source: Phelps 2016] [uncertain].
Reported adverse effects and cautions: Terman & Terman note that some patients in Avery's sigmoidal-dawn work experienced premature awakening at first exposure, occasionally with hypomania, which they did not observe with naturalistic dawns. In their trial, the dim dawn-pulse placebo was associated with residual or worsened depression, including emergent suicidal ideation without intent in two participants [source: Terman & Terman 2006]. For light therapy generally, sources list headache, eye strain, nausea, agitation, possible switch to hypomania or mania in bipolar vulnerability, and need for caution with eye disease and photosensitising medicines [source: Golden et al. 2005; Kaiser; Mayo Clinic; NHS; AFP 2020]. Phelps states he knows of no adverse effects and no hypomania risk from dawn simulators; this is his opinion and conflicts with the reports above [source: Phelps 2016] [uncertain].
Watch for: early waking, agitation, reduced need for sleep, worsening low mood, partner disturbance.
Example language (illustrative): "It's a bedside lamp that slowly brightens in the last part of the night, like an early sunrise. The research is promising but small, and your doctor or sleep specialist would set it up for you." [synthesis]

A2. Consumer wake-up lights, apps and marketing claims

Purpose: to help you and the client judge products. Commercial dawn simulators have been sold since at least the 2000s (a UK manufacturer, now Lumie, patented one in 2005) [source: Wikipedia]. Many models add sounds and a "dusk" fade at bedtime [source: Wikipedia].
What sources say: Smartphone dawn apps (screen or camera flash) are cheap but clinically untested [source: Phelps 2016]. Manufacturer pages cite trials that used their own products and may not mention study limits or device certification; one manufacturer blog reporting a trial of its device gave no regulatory status and no advice to see a doctor [source: Lumie blog]. Devices usually cannot be prescribed in the usual way and insurers rarely cover them [source: Phelps 2016; Kaiser].
Steps [synthesis]: (1) Ask what the client bought or plans to buy and what the box or website claims. (2) Separate claims about waking comfort from claims to treat depression. (3) Note whether a claim cites a trial, who funded it, and whether the device is the one tested. (4) Encourage the client to take the device details to the prescriber or GP.
Example language (illustrative): "The box says it 'beats the winter blues'. That is a marketing line. What the research shows is narrower, and your doctor can say whether this device fits you."
Watch for: the client treating a purchase as a substitute for assessment; spending pressure.

A3. Dusk simulation

Purpose and description: a gradually dimming light at bedtime, studied alongside dawn simulation since the late 1980s and reported to ease sleep onset [source: Wikipedia, citing Terman et al. 1989] [uncertain]. Many consumer devices include it.
Therapist role: ask about it as part of the sleep history; questions about using it for insomnia go to the sleep specialist [synthesis].
Example language (illustrative): "Does your lamp also fade out at bedtime? Let's add that to your sleep notes." [synthesis]
Watch for: dusk features used to manage insomnia without advice. Working: sleep questions reach the sleep specialist. [synthesis]

A4. Use in circadian sleep problems (delayed sleep phase, hard waking)

Description: a secondary source describes moving the simulated dawn earlier in steps to help people with delayed sleep phase wake earlier [source: Wikipedia; no primary or guideline source found] [uncertain].
Therapist role: suspected circadian rhythm sleep-wake disorder is referred to a sleep specialist; do not design a phase-shifting schedule [synthesis].
Example language (illustrative): "If your body clock runs very late, that's something a sleep specialist should look at before any light is used to shift it." [synthesis]
Watch for: self-designed schedules for shifting sleep earlier. Working: a sleep-specialist referral is made. [synthesis]

B1. Screening and recognising when to suggest medical review

Purpose: identify who should see a prescriber, GP, eye specialist or sleep specialist before using dawn simulation. Use when a client reports a winter pattern, owns or is buying a wake-up light, or asks about light treatment.
Steps [synthesis, drawing on cautions in NHS, Mayo Clinic, AFP 2020, Golden et al. 2005]: (1) Map the seasonal pattern: onset and remission months over past years, sleep length, oversleeping, carbohydrate craving, energy. (2) Ask about any past episodes of elevated mood, reduced need for sleep, or a bipolar diagnosis in the client or first-degree relatives. (3) Ask about eye conditions (sources name glaucoma, cataracts, diabetic eye damage) and about medicines or supplements that may increase light sensitivity. (4) Ask about current treatment and who prescribes it. (5) Ask about shift work, irregular sleep, or great difficulty waking (possible circadian disorder). (6) Assess depression severity and suicide risk in the usual way. (7) Any positive answer in steps 2, 3 or 5, moderate-to-severe depression, or current medication: suggest a review before starting.
Example language (illustrative): "Before you set this up, a couple of safety questions: have you ever had spells of feeling unusually high or wired, needing very little sleep? And any eye problems, or medicines your pharmacist said make you sensitive to sunlight?"
Watch for: hypomanic history minimised as "just a good patch"; undiagnosed eye problems in older clients or those with diabetes.

B2. Psychoeducation

Purpose: give an accurate, plain account so the client can decide with the prescriber.
Steps: (1) Explain the idea: a slowly brightening light during the last part of sleep signals morning to the body clock [source: Wikipedia; Terman & Terman 2006]. (2) Explain the evidence honestly: positive trials, mostly from two research groups, with mixed results against light boxes; less established than bright light (see 032) [source: Golden et al. 2005; Terman & Terman 2006; Kaiser]. (3) Explain that settings come from the doctor or sleep specialist, not the box. (4) Name the cautions (B1). (5) Note it works alongside, not instead of, psychotherapy or medication [source: Mayo Clinic].
Example language (illustrative): "Think of it as a gentle artificial sunrise while you're still asleep. Some studies found it helped winter depression; others found it did about as well as a light box, or not much better than a dimmer light. It's a reasonable thing to discuss with your doctor, not a cure on its own."
Watch for: over-expectation; dismissiveness ("just a lamp"); confusion with light boxes.

B3. Supporting informed consent and shared decision-making

Purpose: help the client weigh options (dawn simulation, bright light, medication, CBT for seasonal depression, combinations) with the prescriber.
Steps [synthesis]: (1) List the options the client has heard of. (2) For each, note what matters to the client: effort, time each morning, cost, side effects, household. Dawn simulation's appeal is low effort; Terman & Terman frame it as an alternative to bright light or medication [source: Terman & Terman 2006]. (3) Note the evidence differences from B2. (4) Help write questions for the appointment: "Is it suitable with my history and medicines? What settings and timing? How will we know if it's working? What should make me stop and call you?" (5) Record the decision and who owns it.
Example language (illustrative): "Let's write down what you want to ask Dr X, so you come out with a plan rather than a leaflet."
Watch for: the client deciding alone to avoid medication discussions; feeling pressured either way.

B4. Referral and collaborative care

Purpose: keep the prescriber, GP or sleep specialist informed and involved.
Steps [synthesis]: (1) With consent, write a short note: seasonal pattern, current treatment, client's interest in dawn simulation, any screening flags (bipolarity, eye, medicines, sleep), and risk status. (2) Refer to a sleep specialist when a circadian sleep-wake disorder is suspected. (3) Agree who the client calls about device problems or side effects. (4) Share what you will monitor in sessions.
Example language (illustrative): "I'd like to let your GP know you're thinking of a dawn simulator, given your history of a high spell in 2019. Is that OK?"
Watch for: no clinician owning the light treatment; mixed messages between professionals.

B5. Monitoring and passing on side effects and warning signs

Purpose: catch mood switch, worsening depression or other effects early.
Steps [synthesis, warning signs from Golden et al. 2005; Terman & Terman 2006; Kaiser]: (1) At each session in the winter, briefly check mood, sleep (including earlier waking than intended), energy, irritability, eye strain or headache, and suicidal thinking. (2) Use your usual depression measure regularly. (3) Ask a short hypomania screen if the client has any bipolar features. (4) Pass on to the prescriber promptly: reduced need for sleep, racing thoughts, unusual elation or irritability, new or worse suicidal thoughts, eye symptoms. (5) Do not advise changing the device settings yourself.
Example language (illustrative): "You said you're waking well before the light finishes and feel buzzy. That's worth a call to Dr X today, so they can decide what to do with the settings."
Watch for: improvement that overshoots into hypomania; persisting depression despite use (signal for medical review, not more effort).

B6. Adherence and ambivalence conversations

Purpose: explore practical and motivational barriers without advising any change.
Steps [synthesis]: (1) Ask how use is going and what gets in the way. (2) Explore household issues: a dawn signal can disturb a bed partner on a different schedule [source: Terman & Terman 2006; Phelps 2016]; problem-solve with the couple, and send setting questions to the prescriber. (3) Explore ambivalence with reflective listening (benefits seen, costs, doubts). (4) If the client wants to stop or change, encourage discussion with the prescriber.
Example language (illustrative): "Part of you likes waking more easily, and part of you is fed up because it wakes your partner. What would you want to ask Dr X about that?"
Watch for: unreported stopping; use of extra light boxes or apps on top without medical input.

B7. Integrating psychotherapy before, during and after

Purpose: combine light-based care with evidence-based psychological work.
Steps: (1) Before: assessment, formulation of the seasonal pattern. (2) During: continue structured therapy. CBT for seasonal depression had remission rates similar to light therapy after the first winter and less recurrence in the second winter in Rohan and colleagues' trials [source: AFP 2020, citing Rohan et al. 2015 and 2016]; behavioural activation and regular rise times support a stable morning routine [synthesis]. (3) Use the easier waking as a behavioural anchor for planned morning activities [synthesis]. (4) After: relapse-prevention plan (B9).
Example language (illustrative): "Now you're waking more easily, could the first ten minutes become your walk to the shop? That builds the habit we want for next winter too."
Watch for: the device being credited for everything, reducing engagement in skills.

B8. Crisis and safety planning

Purpose: ensure seasonal depression risk is managed regardless of the device.
Steps [synthesis]: (1) Assess suicide risk using your standard approach. (2) Keep a written safety plan with warning signs, coping steps, contacts and crisis lines. (3) Include mood-switch signs for clients with bipolar features and whom to call. (4) Make clear that any device does not replace urgent care.
Example language (illustrative): "If the dark thoughts get stronger, the plan is the same whatever lamp you're using: these steps, then these people."
Watch for: the client treating the device as their safety plan, or mood falling despite use. Working: the plan is used and updated. [synthesis]

B9. End-of-season review and support after treatment

Purpose: consolidate gains and plan for next autumn.
Steps [synthesis]: (1) Review what helped (device, therapy skills, medication, activity). (2) Write early-warning signs and the month to act. (3) Agree when to contact the prescriber before next winter to plan light treatment. (4) Note that the 2005 meta-analysis did not settle optimal use, so ongoing decisions are medical [source: Golden et al. 2005].
Example language (illustrative): "When you notice the first signs in October, the plan is: book Dr X, restart your activity schedule, and come back to see me."
Watch for: plans that lapse over the summer, or waiting until symptoms are established. Working: early contact with the prescriber in autumn. [synthesis]

5. Handling problems

The research sources address few of these; responses are [synthesis] unless tagged.

No improvement after weeks of use. Do not suggest brighter, longer or earlier light. Review depression severity and risk, strengthen the psychotherapy, and prompt a medical review; the prescriber may consider other options such as bright light (see 032), medication or CBT for seasonal depression [source for options: AFP 2020; Terman & Terman 2006].
Signs of hypomania or mania (less sleep, elation, irritability, racing thoughts). Contact the prescriber the same day with consent; follow your service's urgent pathway if risk is high. Sources link light therapy to switch in vulnerable people, and early waking with occasional hypomania was reported with one sigmoidal dawn [source: Golden et al. 2005; Terman & Terman 2006]. Do not tell the client to stop the device; pass the decision to the prescriber, unless an emergency service directs otherwise.
Worsening depression or new suicidal thoughts. Risk assessment and safety plan (B8). Note that a dim dawn-pulse condition in one trial was linked with worse outcomes including emergent suicidal ideation in two participants [source: Terman & Terman 2006]; treat any deterioration as a reason for medical review, not as a device problem.
Eye discomfort, headache or blurred vision. Pass on to the prescriber; suggest eye-specialist advice for anyone with eye disease [source: Mayo Clinic; AFP 2020; Kaiser].
Client uses an app or cheap device instead of seeing a doctor. Respect autonomy; explain that apps are clinically untested [source: Phelps 2016], complete the B1 screen, and encourage the GP to be informed. Document the conversation.
Partner conflict or disturbed household sleep. Use couple problem-solving about bedroom and schedule; questions about settings go to the prescriber [source for the problem: Terman & Terman 2006; Phelps 2016].
Non-adherence (forgets to set it, switches it off). Explore barriers (B6); link setting the device to the bedtime routine; normalise the effort; check whether low mood itself is the barrier.
Over-reliance or magical expectations. Keep the device in its place in the formulation; review what the client does differently on good mornings; keep therapy goals active.
Overwhelm at the number of options. Reduce to one decision at a time; use the B3 question list; let the prescriber make the medical choice.
Rupture: client feels the therapist is gatekeeping a harmless gadget. Acknowledge that many people use wake-up lights without problems; explain the screening is about their particular history (bipolar, eyes, medicines), not doubt about them; invite repair.
Client also has shift work or a very late body clock. Refer to a sleep specialist; light timing in circadian disorders is a specialist decision [source for description: Wikipedia] [uncertain].
Client asks you to advise settings. Decline kindly and route to the prescriber or sleep specialist; offer to help prepare questions.
Cost and access. Devices are seldom prescribable or reimbursed [source: Phelps 2016; Kaiser]; help the client weigh cost against other options with the prescriber; avoid endorsing brands.

Sources

Sources:

Further reading (not drawn on; details as given in the sources above):

Avery DH et al. (2001). Dawn simulation and bright light in the treatment of SAD: a controlled study. Biological Psychiatry, 50(3), 205–216 [uncertain].
Terman M, Terman JS (2006). Controlled trial of naturalistic dawn simulation and negative air ionization for seasonal affective disorder. American Journal of Psychiatry, 163(12), 2126–2133 (authors and pages per Wikipedia).
Terman M, Schlager D, Fairhurst S, Perlman B (1989). Dawn and dusk simulation as a therapeutic intervention. Biological Psychiatry, 25(7), 966–970 [uncertain].
Danilenko and colleagues (2015, as reported by Lumie and Phelps). Trial of dawn simulation versus bright light in winter depression. Journal of Affective Disorders [uncertain: full citation not checked].
Rohan et al. (2015; 2016). CBT versus light therapy for SAD trials, American Journal of Psychiatry 172(9) and 173(3) (as cited in AFP 2020).
CANMAT 2023 update on major depressive disorder, Canadian Journal of Psychiatry, DOI 10.1177/07067437241245384 (as linked from the UBC page) [uncertain].

← Previous · IX-032Bright-light therapy Next · IX-034 →Wake therapy and triple chronotherapy